Related Experiment Video
Updated: May 11, 2026
09:02
Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation
Published on: November 26, 2018
Genetic differences between Asian and Caucasian chronic lymphocytic leukemia
Norihiko Kawamata1, Chimene Moreilhon, Takayuki Saitoh
1Hematology/Oncology, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA. kawamatan@cshs.org
International Journal of Oncology
|May 28, 2013
Summary
Genetic abnormalities in chronic lymphocytic leukemia (CLL) are similar between Asian and Caucasian patients, with some ethnic-specific differences. This study identified common and novel genomic alterations in CLL across ethnic groups.
Area of Science:
- Hematological Malignancies
- Genomics
- Cancer Research
Background:
- Chronic lymphocytic leukemia (CLL) is a prevalent hematological malignancy in Western populations but rare in Asia.
- The underlying genetic mechanisms driving CLL development in different ethnic groups remain unclear.
Purpose of the Study:
- To compare genetic abnormalities in Chronic lymphocytic leukemia (CLL) between Asian and Caucasian populations.
- To identify common and distinct genomic alterations contributing to CLL pathogenesis in diverse ethnicities.
Main Methods:
- Utilized 250k GeneChip arrays to analyze genomic profiles of Asian and Caucasian CLL patients.
- Compared the frequency and types of genetic abnormalities, including deletions, trisomies, and amplifications.
Main Results:
- Identified four common genetic abnormalities in both groups: deletion of 13q14.3, trisomy 12, ATM (11q) abnormalities, and 17p abnormalities.
- Observed mutual exclusivity between trisomy 12 and deletion of 13q14.3 in both ethnic groups.
- Found Asian CLL exhibited a higher frequency of 3q and 18q gains, alongside novel alterations like IRF4 amplification and SP140/SP100 deletion.
Conclusions:
- Classic genomic changes in Chronic lymphocytic leukemia (CLL) are largely conserved across Asian and Caucasian populations.
- Identified both shared and novel genomic alterations, including IRF4 amplification and SP140/SP100 deletion, contributing to CLL development.
